United Kingdom Diabetes Care Devices Market Insight
UK diabetes care devices market grows at around 7.05% CAGR, driven by CGM adoption, NHS support, and 4.3+ million patients, Abbott Laboratories drives innovation improving monitoring accuracy and outcomes
United Kingdom Diabetes Care Devices Market Insights Forecasts to 2035
- The United Kingdom Diabetes Care Devices Market Size Was Estimated at USD 90.25 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.05% from 2025 to 2035
- The United Kingdom Diabetes Care Devices Market Size is Expected to Reach USD 178.4 Million by 2035
Notable Insights for United Kingdom Diabetes Care Devices Market
- By device type, blood glucose monitoring (BGM) devices dominated, accounting for approximately 55–60% share in 2025, contributing nearly USD 1.8–2.1 Billion, due to widespread daily usage among diabetic patients.
- By end user, home care settings dominated, accounting for approximately 60–65% share, contributing around USD 2.0–2.3 Billion, driven by increasing preference for self-monitoring and remote diabetes management.
- Approximately 4.3–4.6 million people in the UK live with diabetes, with over 90% diagnosed with Type 2 diabetes, highlighting the substantial burden of chronic disease across the population.
- Nearly 35–40% of patients use advanced monitoring devices such as CGM or insulin pumps, while the UK holds a significant share of Europe’s market due to strong healthcare access.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Diabetes Care Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Diabetes Care Devices Market
- Abbott Laboratories
- Dexcom
- Medtronic
- Roche
- Ascensia Diabetes Care
- Insulet Corporation
- Novo Nordisk
- Others
Recent Developments:
- In April 2026, Roche Accu-Chek SmartGuide CGM launched in phased UK NHS rollout offering real-time glucose monitoring with AI-powered overnight hypoglycaemia prediction and selected regional reimbursement for eligible diabetes patients.
- In April 2024 – NHS England launched a 5-year artificial pancreas rollout, allocating initial £2.5 million to expand hybrid closed-loop systems for thousands of type 1 diabetes patients.
Market Segmentation:
United Kingdom Diabetes Care Devices Market, By Device Type
- Blood Glucose Monitoring Devices
- Continuous Glucose Monitoring (CGM) Systems
- Insulin Delivery Devices
United Kingdom Diabetes Care Devices Market, By End User
- Hospitals & Clinics
- Home Care Settings
United Kingdom Diabetes Care Devices Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
Expert Views:
The United Kingdom Diabetes Care Devices Market is poised for strong growth, driven by increasing diabetes prevalence, technological advancements, and growing adoption of digital health solutions. Experts highlight that continuous glucose monitoring, wearable devices, and AI-integrated diabetes management systems will dominate the market. With rising demand for personalized and remote care, companies focusing on innovation and patient-centric solutions will play a critical role in improving outcomes and expanding mark